Can Bortezomib treat stomach cancer?

Bortezomib (Bortezomib) is a new type of immunotherapy drug, mainly used to treat multiple myeloma (MM) and lymphoma. Currently, bortezomib is not a standard treatment for gastric cancer. Treatment options for gastric cancer usually involve a variety of methods including surgical resection, radiation therapy, and chemotherapy, depending on the patient's condition and the stage of the tumor. In animal studies, bortezomib enhanced the efficacy of TRAIL against tumor xenografts and endogenous cancers. In addition, TRAIL is associated with the anti-tumor effects of NK cells, which can be enhanced by bortezomib treatment.